SOFTWAY MEDICAL
Acquired by
BAIN CAPITAL
SOFTWAY MEDICAL acquired by BAIN CAPITAL
Target
SOFTWAY MEDICAL
Acquirer
BAIN CAPITAL
Context
Bain Capital acquired a majority stake in Softway Medical from Five Arrows and Naxicap Partners, valuing the group at an Enterprise Value (EV) above EUR1.0 billion. This landmark transaction marks a major transition for the French software publisher, aiming to transform a national leader into a pan-European champion. The historical shareholders, Five Arrows and Naxicap, reinvested significantly alongside the management team.
SOFTWAY MEDICAL, which reported an EBITDA margin of LOGIN in 2024, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN premium to the 13.6x average currently observed in the TMT (Tech, Media, Telecom) sector.
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in TMT (Tech, Media, Telecom) market trends
Target
Founded in 1999, Softway Medical is the French leader in cloud-native software solutions for healthcare institutions. The group acts as a publisher, host (HDS certified), and integrator, offering a comprehensive suite of digital tools including Electronic Health Records (EHR) for hospitals, Radiology Information Systems (RIS/PACS), and Laboratory Information Systems (LIS). Its flagship e-Novation platform serves over 1,300 hospitals and clinics (representing a 40% market share in France), 1,300 imaging centers, and 400 laboratories.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples Analysis
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Other operations with SOFTWAY MEDICAL
mynth data is contributed by M&A / PE professionals and systematically cross-verified against private deal documents and official releases. All source materials are destroyed post-validation to guarantee data anonymity and compliance.